• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Companion Medical

Medtronic launches ‘smart’ insulin pen

November 12, 2020 By Nancy Crotti

Medtronic (NYSE:MDT) today announced the launch of its InPen “smart” insulin pen integrated with real-time Guardian Connect continuous glucose monitor (CGM) data. The Fridley, Minn.-based medtech giant is touting InPen is the first and only FDA-cleared smart insulin pen on the market for people on multiple daily insulin injections. The system is designed to provide real-time […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: Companion Medical, Medtronic

Medtronic CEO Geoff Martha: ‘Time to be bold and add grit’

October 14, 2020 By Sean Whooley

Medtronic (NYSE:MDT) CEO Geoff Martha has no intention of slowing the medtech giant down amid the COVID-19 pandemic. Speaking during the Fridley, Minn.-based company’s “Investor Day” virtual presentation, Martha made one thing clear: “We are going on the offensive,” Martha said at the start and echoed throughout the program. About six months into his tenure as […]

Filed Under: Big Data, Business/Financial News, Cardiac Implants, Cardiovascular, Clinical Trials, Diabetes, Digital Health, Featured, Food & Drug Administration (FDA), Health Technology, Imaging, MassDevice Earnings Roundup, Mergers & Acquisitions, Regulatory/Compliance, Replacement Heart Valves, Research & Development, Software / IT, Structural Heart, Surgical, Surgical Robotics, Wall Street Beat Tagged With: Companion Medical, coronavirus, COVID-19, Edwards Lifesciences, Intuitive Surgical, Medtronic, tavr, The Blackstone Group LP, The Foundry

Medtronic to acquire Companion Medical, expands diabetes business

August 11, 2020 By Danielle Kirsh

Medtronic (NYSE:MDT) today said it would acquire insulin pen manufacturer Companion Medical for an undisclosed amount. Companion Medical’s product portfolio includes the InPen FDA-cleared smart insulin pen system that is paired with an integrated diabetes management app on the market. It is designed to help calculate insulin doses, track active insulin and send reports to caregivers […]

Filed Under: Business/Financial News, Diabetes, Featured, Mergers & Acquisitions Tagged With: Companion Medical, Medtronic

Companion Medical wins FDA nod for InPen diabetes management system

February 28, 2020 By Sean Whooley

Companion Medical announced that it won FDA clearance for its InPen bolus calculator for fixed dosing and meal estimation in diabetes management. The new bolus calculator is designed to account for the user’s current glucose level and active insulin to remove the guesswork from insulin dosing. Companion Medical touts the system as the first of its […]

Filed Under: Diabetes, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance Tagged With: Companion Medical, FDA

Senseonics, Companion Medical to integrate sensor glucose and insulin data

February 11, 2020 By Sean Whooley

Senseonics (NYSE:SENS) will integrate its Eversense continuous glucose monitoring (CGM) system’s real-time glucose data with Companion Medical‘s InPen smart insulin delivery system. The agreement between Senseonics and Companion, announced today, is slated to bring the technologies together to allow real-time glucose data to be continuously incorporated into the InPen insulin system. This is designed to allow for more relevant […]

Filed Under: Business/Financial News, Diabetes, Digital Health Tagged With: Companion Medical, Senseonics

Dexcom, Companion Medical will share glucose, insulin data

June 7, 2019 By Nancy Crotti

DexCom (NSDQ:DXCM) and Companion Medical have announced a collaboration to enable a direct exchange of continuous glucose monitoring (CGM) data from Dexcom with insulin data from InPen into both companies’ software applications. Companion made a partnership deal with Glooko this week to integrate data from its InPen smart insulin injection pen into Glooko’s diabetes data management system and mobile […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, News Well Tagged With: American Diabetes Association, Companion Medical, Dexcom

Companion Medical, Glooko ink InPen insulin pen data integration deal

June 5, 2019 By Fink Densford

Companion Medical said today that it inked a partnership deal with Glooko to integrate data from its InPen smart insulin injection pen into Glooko’s diabetes data management system and mobile application. The integration will be performed through Apple‘s (NSDQ:AAPL) Apple Health application, San Diego-based Companion Medical said, and will allow users to automatically integrate insulin data […]

Filed Under: Business/Financial News, Diabetes, Software / IT Tagged With: Companion Medical, Glooko

Companion Medical wins CE Mark for InPen insulin pen

July 20, 2018 By Fink Densford

Companion Medical said yesterday that it won CE Mark approval in the European Union for its InPen smart insulin pen and associated diabetes management smartphone application. The company’s InPen system consists of a smart insulin injection pen that connects with an integrated diabetes management app. Read the whole story on our sister site, Drug Delivery Business […]

Filed Under: Diabetes, Drug-Device Combinations, Regulatory/Compliance Tagged With: Companion Medical

Companion Medical wins FDA nod for Android version of smart pen app

July 9, 2018 By Sarah Faulkner

Companion Medical said today that it won FDA clearance for the Android version of its InPen app. The company’s InPen system consists of a smart insulin injection pen that connects with an integrated diabetes management app. Companion Medical expects to release the app for Android users by the fourth quarter of this year. Get the full […]

Filed Under: Diabetes, Drug-Device Combinations, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance, Wall Street Beat Tagged With: Companion Medical

Companion Medical launches data management system for smart insulin pen

June 21, 2018 By Sarah Faulkner

Companion Medical launched today Insights by InPen, a diabetes management system that aggregates and analyzes data from Companion’s connected insulin injection pen. The company’s Insights by InPen system provides users with their average glucose, average total daily insulin dose, dose calculator usage, missed doses and more, according to Companion Medical. Get the full story at our […]

Filed Under: Diabetes, Drug-Device Combinations, Pharmaceutical Tagged With: Companion Medical

Meet the insulin-makers and device companies developing smart insulin pens

March 19, 2018 By Sarah Faulkner

The global market for connected insulin pens could be worth up to $123 million by 2023, according to a report published this year by Research & Markets. Insulin pens, designed for people who control their diabetes with multiple daily injections instead of a pump or wearable patch, are portable devices that were first introduced in 1985 with […]

Filed Under: Diabetes, Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: Companion Medical, Dexcom, Eli Lilly & Co., Glooko, Novo Nordisk

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy